Histone deacetylase inhibitors
US7642253B2 · kind B2 · utility
0Cited by
83References
57Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 10, 2006 |
| Grant date | Jan 5, 2010 |
| Priority date | — |
| Expiry date | May 22, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds, pharmaceutical compositions, kits and methods useful for inhibiting HDAC, thereby treating a disease state for which HDAC possess activity that contributes to the pathology and/or symptomology of the disease state. The compound is selected from the group consisting of:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.